Faeth Therapeutics (FTH) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 25 67 sessions, June 16, 2026 to September 21, 2026
- Largest daily move
- +30.1% close of June 22, 2026
Company Description
Faeth Therapeutics (NASDAQ: FTH) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $839.3M.
FTH has gained 4.0% over the past month. The last closing price was $33.29.
For FY2025, Faeth Therapeutics reported net income of -$21.1M and diluted earnings per share of -$16.72.
This page collects what Stock Titan holds for FTH, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Faeth Therapeutics (FTH) closed at $33.29 on September 21, 2026. Over the past month, the price has gained 4.0%.
FTH Metrics & Rankings
Price returns through September 21, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Faeth Therapeutics has 10 recent news articles, with the latest published 5 days ago. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include management, clinical trial, fda approval, conferences, earnings. View all FTH news →
SEC Filings
Faeth Therapeutics has filed 10 recent SEC filings, including 3 Form SCHEDULE 13G/A, 2 Form 8-K, 1 Form 3, 1 Form 4. The most recent filing was submitted on September 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all FTH SEC filings →
Insider Radar
Insider buying activity at Faeth Therapeutics over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
operating income reached -$22.3M, and net income was -$21.1M. Diluted earnings per share stood at -$16.72. The company generated -$20.5M in operating cash flow. With a current ratio of 5.06, the balance sheet reflects a strong liquidity position.
Upcoming Events
Virtual KOL event
Interim Phase 1b/2 readout
Options full vesting
Inducement Option Expiry
Option expiration
Faeth Therapeutics has 5 upcoming scheduled events. The next event, "Virtual KOL event", is scheduled for October 6, 2026 (in 14 days). 2 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the FTH stock price.
Short Interest History
Short interest in Faeth Therapeutics (FTH) currently stands at 1.1 million shares, up 32.8% from the previous reporting period, representing 4.5% of the float. Since June 2026, short interest has increased by 40.7%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Faeth Therapeutics (FTH) currently stands at 3.7 days, up 33.5% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has decreased 47.2% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 2.8 to 7.0 days.
FTH Company Profile & Sector Positioning
Faeth Therapeutics (FTH) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.